ArticleHaematologica2022

Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia.

Steven Goossens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.